Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
Name
Regev_Integrative genomic.pdf
Size
1.97 MB
Format
Adobe PDF
Checksum (MD5)
c846ad31d22303a9ae75836d351fd71d
Author(s)
Brown, Jennifer R.
Hanna, Megan
Tesar, Bethany
Werner, Lillian
Pochet, Nathalie
Asara, John M.
Wang, Yaoyu E.
dal Cin, Paola
Fernandes, Stacey M.
Thompson, Christina
Date Issued
May 2012
Journal
Clinical Cancer Research
Publisher
American Association for Cancer Research
Citation
Brown, J. R., M. Hanna, B. Tesar, L. Werner, N. Pochet, J. M. Asara, Y. E. Wang, et al. “Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia.” Clinical Cancer Research 18, no. 14 (July 15, 2012): 3791-3802.
Version
Author's final manuscript
Abstract
Purpose: The disease course of chronic lymphocytic leukemia (CLL) varies significantly within cytogenetic groups. We hypothesized that high-resolution genomic analysis of CLL would identify additional recurrent abnormalities associated with short time-to-first therapy (TTFT).
Experimental Design: We undertook high-resolution genomic analysis of 161 prospectively enrolled CLLs using Affymetrix 6.0 SNP arrays, and integrated analysis of this data set with gene expression profiles.
Results: Copy number analysis (CNA) of nonprogressive CLL reveals a stable genotype, with a median of only 1 somatic CNA per sample. Progressive CLL with 13q deletion was associated with additional somatic CNAs, and a greater number of CNAs was predictive of TTFT. We identified other recurrent CNAs associated with short TTFT: 8q24 amplification focused on the cancer susceptibility locus near MYC in 3.7%; 3q26 amplifications focused on PIK3CA in 5.6%; and 8p deletions in 5% of patients. Sequencing of MYC further identified somatic mutations in two CLLs. We determined which catalytic subunits of phosphoinositide 3-kinase (PI3K) were in active complex with the p85 regulatory subunit and showed enrichment for the α subunit in three CLLs carrying PIK3CA amplification.
Conclusions: Our findings implicate amplifications of 3q26 focused on PIK3CA and 8q24 focused on MYC in CLL.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1158/1078-0432.ccr-11-2342
